For decades, ultrasound has been used to image organs such as the heart and kidneys, check blood flow, monitor the development of fetuses, reduce pain and even break up kidney stones.
Now, a Norwegian biotech company called Phoenix Solutions AS is working with the Translational Genomics Research Institute (TGen), a Phoenix, Arizona-based biomedical research facility, to test the use of these pulsed sound waves to direct and focus cancer drug therapies.
In laboratory tests, TGen will help analyze the effectiveness of a technology called Acoustic Cluster Therapy (ACT), a unique approach to targeting cancer cells by concentrating the delivery of chemotherapies, making them more effective and potentially reducing their toxicity.
Humanscan Co. Ltd., a South Korean manufacture of ultrasound diagnostic imaging, is developing clinically applicable hardware optimized for ACT, which TGen will then validate.
Phoenix Solutions is using funding from Innovation Norway to conduct this research in advance of pancreatic cancer clinical trials planned later this year.
“We are very pleased to receive this grant, which will enable us to develop and validate an optimal ultrasound platform for clinical use of ACT. In their respective fields, Humanscan and TGen both represent the cutting edge of science, and we are confident this will contribute to the clinical success of our program,” said Dr. Per Sontum, CEO of Phoenix Solutions.
TGen is a world leader in the development of novel therapeutics for the treatment of pancreatic cancer. The TGen team led the clinical development of one of the current standard-of-care regimens for this disease — nab-paclitaxel plus gemcitabine. TGen currently is involved in 13 pancreatic cancer clinical programs.
“We are pleased that this research program has become a reality, and look forward to working with ACT. The concept represents a novel approach to targeted drug delivery and looks very promising,” said Dr. Haiyong Han, a Professor in TGen’s Molecular Medicine Division and head of the Basic Research Unit in TGen’s Pancreatic Cancer Program.
Among the advantages of ultrasound technology: it is generally painless; non-invasive; does not require needles, injections or incisions; and patients are not exposed to ionizing radiation, making the procedure safer than diagnostic techniques such as X-rays and CT scans.
Humanscan CEO Sungmin Rhim said, “We are excited to enter into this collaboration with Phoenix (Solutions) and participate in the development of ACT. Ultrasound mediated, targeted drug delivery is an emerging therapy approach with great potential and we are delighted to be in the forefront of this development.”
Phoenix Solutions also is considering this technology for use in addressing other types of cancer, including: liver, prostate and triple-negative breast cancer; and other diseases, including those involving inflammation and the central nervous system.
The Latest on: Cancer drug delivery
via Google News
The Latest on: Cancer drug delivery
X-rays burst chemo-filled nanobubbles for targeted cancer drug delivery
on July 15, 2018 at 8:16 pm
A new potential cancer treatment uses nanobubbles called liposomes to ... "Liposomes are already well established as an extremely effective drug-delivery system," says Wei Deng, lead author of the stu... […]
Novel Drug Delivery Systems In Cancer Therapy Market Projected To Boost On Account Of Rising Cases Of Cancer Till 2025: Grand View Research, Inc.
on July 12, 2018 at 12:15 pm
(MENAFN Editorial) According to a report by Grand View Research, Inc., global novel drug delivery systems (NDDS) in cancer therapy market is anticipated to value USD 26.61 billion by 2025. Growing req... […]
Novel Drug Delivery Systems In Cancer Therapy Market Projected T - KPLC 7 News, Lake Charles, Louisiana
on July 11, 2018 at 5:00 pm
According to a report by Grand View Research, Inc., global novel drug delivery systems (NDDS) in cancer therapy market is anticipated to value USD 26.61 billion by 2025. Growing requirement for advanc... […]
Ultrasound remotely bursts heat-sensitive capsules, delivering drugs directly to tumors
on July 11, 2018 at 1:47 am
A promising new cancer drug delivery system has successfully passed early human safety trials. The treatment delivers cancer drugs in heat-activated capsules to tumors in the liver and then uses a foc... […]
Cancer: 'Intelligent drug delivery' is on its way
on July 9, 2018 at 8:12 am
Healthline Media, Inc. would like to process and share personal data (e.g., mobile ad id) and data about your use of our site (e.g., content interests) with our third party partners (see a current lis... […]
Novel gold nanocomplex for cancer drug delivery
on June 16, 2018 at 8:54 pm
Using gold nanoparticles coated with a simple organic molecule (porphyrin), researchers from CSIR-Indian Institute of Chemical Biology, Kolkata, have designed an efficient drug nanocarrier. The nanoca... […]
'Uber' drug delivery for cancer patients
on June 8, 2018 at 5:45 am
PhD candidates Samantha Wade and Sepehr Talebian, Dr Javad Foroughi, Distinguished Professor Gordon Wallace and Dr Kara Vine-Perrow. Credit: Alex Pike Cancer remains one of the major causes of death i... […]
Global Cancer Drug Delivery Report 2018: Cancer Market Estimates 2017-2027 by Organs, Types of Cancer & Technologies
on May 16, 2018 at 1:36 pm
Dublin, May 16, 2018 (GLOBE NEWSWIRE) -- The "Drug Delivery in Cancer - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. Cancer ... […]
Cancer Drug Delivery Technologies, Markets and Companies 2017-2027 - Focus on Targeted Cancer Therapy - ResearchAndMarkets.com
on May 16, 2018 at 5:00 am
The "Drug Delivery in Cancer - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. Cancer drug delivery is no longer simply wrappin... […]
via Bing News